News

Glossary Blog, March 2018: Tumor Sequencing Tumor Sequencing: A laboratory method that is used to determine the entire genetic makeup of specific tumor cell types by identifying the exact sequence (order) of the four building blocks, or bases, that make up its DNA. This method can be used to find changes in areas of the genome. These changes may help scientists understand how specific […] March 28, 2018

Brain Tumor Research Highlights: March 2018 Over the years, NBTS has given nearly $40 million to brain tumor research projects. We’re very proud of the impact this funding has made in advancing the neuro-oncology field closer to better treatments and ultimately a cure. And while NBTS is currently focused on driving our flagship research projects – like the Defeat GBM (glioblastoma) Research Collaborative – […] March 23, 2018

(Updated) Glossary Blog: CAR-T Cell Therapy CAR-T cell Therapy: A type of treatment in which a patient’s T cells (a type of immune system cell) are changed in the laboratory so they will attack cancer cells. T cells are taken from a patient’s blood. Then the gene for a special receptor that binds to a certain protein on the patient’s cancer […] February 27, 2018

Beating the Odds Thanks to Research Funding: Greg’s Story After an otherwise-healthy and vibrant 24-year old newlywed was diagnosed with an aggressive brain tumor and given just two-to-three years to live, a new clinical trial – based on NBTS-funded research – provided hope and helped beat the odds. “Temozolomide is what it is: a chemotherapy,” says Greg. “This means constantly feeling drained of your […] November 13, 2017

NBTS Scientific Summit 2017: Making a “New Map” for Brain Tumor Research & Treatment Development Twelve questions to answer that will drive the brain tumor research field forward “I think that this year is even more accelerated in progress than last year. Lots of new things, lots of new possibilities…we really are all pushing together and trying to get to the top of the mountain.” With those words, Dr. Web […] November 2, 2017